PRESS RELEASE published on 10/01/2024 at 07:00, 1 year 9 months ago Informations privilégiées / Autres communiqués Advicenne franchit des étapes majeures aux Etats-Unis pour ADV7103 avec des avis favorables de la FDA, ouvrant des opportunités partenariales, simplifiant les démarches réglementaires et cliniques FDA Développement États-Unis Partenaires Advicenne
BRIEF published on 05/15/2024 at 09:07, 2 years 1 month ago Les actionnaires d'Advicenne approuvent les résolutions soutenues par le conseil d'administration lors de l'assemblée générale Assemblée Générale Euronext Croissance Paris Industrie Pharmaceutique Conseille Maladies Rénales Rares
BRIEF published on 05/15/2024 at 09:07, 2 years 1 month ago Advicenne Shareholders Approve Board-Supported Resolutions at General Meeting Euronext Growth Paris Pharmaceutical Industry General Meeting Advicenne Rare Renal Diseases
PRESS RELEASE published on 05/15/2024 at 09:02, 2 years 1 month ago Inside Information / Other news releases Advicenne's Board of Directors' resolutions approved at the Combined General Meeting. Shareholders support all resolutions including financial statements and delegations Board Of Directors Shareholders Financial Statements Combined General Meeting Advicenne
BRIEF published on 05/15/2024 at 08:06, 2 years 1 month ago Advicenne lance un programme de rachat d'actions Marché Financier Rachat D'actions Euronext Growth Advicenne Maladies Rénales
BRIEF published on 05/15/2024 at 08:06, 2 years 1 month ago Advicenne launches a share buyback program Share Buyback Euronext Growth Financial Market Advicenne Kidney Diseases
PRESS RELEASE published on 05/15/2024 at 08:01, 2 years 1 month ago Informations privilégiées / Autres communiqués Advicenne annonce un programme de rachat d'actions autorisé par son assemblée générale mixte. Le programme permet l'achat de jusqu'à 10% du capital social avec un prix maximum de 21 euros par action Rachat D'actions Euronext Growth Programme Autorisation Advicenne
Published on 07/14/2026 at 01:45, 1 hour 25 minutes ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 3 hours 9 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 21:35, 5 hours 35 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 7 hours 10 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/13/2026 at 22:30, 4 hours 40 minutes ago Half-year 2026 Results Media and Investor Conference Call and Webcast
Published on 07/13/2026 at 21:20, 5 hours 50 minutes ago Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 5 hours 52 minutes ago EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 20:48, 6 hours 22 minutes ago EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026
Published on 07/13/2026 at 20:23, 6 hours 47 minutes ago EQS-Adhoc: TRATON SE: Preliminary operating result for Q2 2026 exceeds market expectations
Published on 07/13/2026 at 18:00, 9 hours 10 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 9 hours 10 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 9 hours 10 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
